178 related articles for article (PubMed ID: 32298357)
1. Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets.
Korolkova OY; Widatalla SE; Whalen DS; Nangami GN; Abimbola A; Williams SD; Beasley HK; Reisenbichler E; Washington MK; Ochieng J; Mayer IA; Lehmann BD; Sakwe AM
PLoS One; 2020; 15(4):e0231711. PubMed ID: 32298357
[TBL] [Abstract][Full Text] [Related]
2. Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer.
Li T; Tao Z; Zhu Y; Liu X; Wang L; Du Y; Cao J; Wang B; Zhang J; Hu X
Cell Death Dis; 2021 Jul; 12(7):684. PubMed ID: 34238922
[TBL] [Abstract][Full Text] [Related]
3. Diverse Roles of Annexin A6 in Triple-Negative Breast Cancer Diagnosis, Prognosis and EGFR-Targeted Therapies.
Korolkova OY; Widatalla SE; Williams SD; Whalen DS; Beasley HK; Ochieng J; Grewal T; Sakwe AM
Cells; 2020 Aug; 9(8):. PubMed ID: 32784650
[TBL] [Abstract][Full Text] [Related]
4. Reduced annexin A6 expression promotes the degradation of activated epidermal growth factor receptor and sensitizes invasive breast cancer cells to EGFR-targeted tyrosine kinase inhibitors.
Koumangoye RB; Nangami GN; Thompson PD; Agboto VK; Ochieng J; Sakwe AM
Mol Cancer; 2013 Dec; 12(1):167. PubMed ID: 24354805
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-Inducible Expression of Annexin A6 Enhances the Resistance of Triple-Negative Breast Cancer Cells to EGFR and AR Antagonists.
Williams SD; Smith TM; Stewart LV; Sakwe AM
Cells; 2022 Sep; 11(19):. PubMed ID: 36230969
[TBL] [Abstract][Full Text] [Related]
6. Implication of calcium activated RasGRF2 in Annexin A6-mediated breast tumor cell growth and motility.
Whalen DS; Widatalla SE; Korolkova OY; Nangami GS; Beasley HK; Williams SD; Virgous C; Lehmann BD; Ochieng J; Sakwe AM
Oncotarget; 2019 Jan; 10(2):133-151. PubMed ID: 30719209
[TBL] [Abstract][Full Text] [Related]
7. Lapatinib-induced annexin A6 upregulation as an adaptive response of triple-negative breast cancer cells to EGFR tyrosine kinase inhibitors.
Widatalla SE; Korolkova OY; Whalen DS; Goodwin JS; Williams KP; Ochieng J; Sakwe AM
Carcinogenesis; 2019 Aug; 40(8):998-1009. PubMed ID: 30590459
[TBL] [Abstract][Full Text] [Related]
8. Annexin A6 improves anti-migratory and anti-invasive properties of tyrosine kinase inhibitors in EGFR overexpressing human squamous epithelial cells.
Hoque M; Elmaghrabi YA; Köse M; Beevi SS; Jose J; Meneses-Salas E; Blanco-Muñoz P; Conway JRW; Swarbrick A; Timpson P; Tebar F; Enrich C; Rentero C; Grewal T
FEBS J; 2020 Jul; 287(14):2961-2978. PubMed ID: 31869496
[TBL] [Abstract][Full Text] [Related]
9. Annexin A6-A multifunctional scaffold in cell motility.
Grewal T; Hoque M; Conway JRW; Reverter M; Wahba M; Beevi SS; Timpson P; Enrich C; Rentero C
Cell Adh Migr; 2017 May; 11(3):288-304. PubMed ID: 28060548
[TBL] [Abstract][Full Text] [Related]
10. SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU/AKT1-involved EMT in hepatocellular carcinoma.
Yang Y; Huang L; Zhang N; Deng YN; Cao X; Liang Y; Hou H; Luo Y; Yang Y; Li Q; Liang S
Cell Commun Signal; 2024 Apr; 22(1):206. PubMed ID: 38566133
[TBL] [Abstract][Full Text] [Related]
11. Annexin A6 contributes to the invasiveness of breast carcinoma cells by influencing the organization and localization of functional focal adhesions.
Sakwe AM; Koumangoye R; Guillory B; Ochieng J
Exp Cell Res; 2011 Apr; 317(6):823-37. PubMed ID: 21185831
[TBL] [Abstract][Full Text] [Related]
12. Reduced Expression of Annexin A6 Induces Metabolic Reprogramming That Favors Rapid Fatty Acid Oxidation in Triple-Negative Breast Cancer Cells.
Williams SD; Sakwe AM
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267416
[TBL] [Abstract][Full Text] [Related]
13. Annexin A6 and Late Endosomal Cholesterol Modulate Integrin Recycling and Cell Migration.
García-Melero A; Reverter M; Hoque M; Meneses-Salas E; Koese M; Conway JR; Johnsen CH; Alvarez-Guaita A; Morales-Paytuvi F; Elmaghrabi YA; Pol A; Tebar F; Murray RZ; Timpson P; Enrich C; Grewal T; Rentero C
J Biol Chem; 2016 Jan; 291(3):1320-35. PubMed ID: 26578516
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface.
Nelson ER; Li S; Kennedy M; Payne S; Kilibarda K; Groth J; Bowie M; Parilla-Castellar E; de Ridder G; Marcom PK; Lyes M; Peterson BL; Cook M; Pizzo SV; McDonnell DP; Bachelder RE
Oncotarget; 2016 Dec; 7(51):84030-84042. PubMed ID: 27768598
[TBL] [Abstract][Full Text] [Related]
15. Annexin A6 inhibits Ras signalling in breast cancer cells.
Vilá de Muga S; Timpson P; Cubells L; Evans R; Hayes TE; Rentero C; Hegemann A; Reverter M; Leschner J; Pol A; Tebar F; Daly RJ; Enrich C; Grewal T
Oncogene; 2009 Jan; 28(3):363-77. PubMed ID: 18850003
[TBL] [Abstract][Full Text] [Related]
16. Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles.
Kannan A; Philley JV; Hertweck KL; Ndetan H; Singh KP; Sivakumar S; Wells RB; Vadlamudi RK; Dasgupta S
Sci Rep; 2019 Aug; 9(1):11632. PubMed ID: 31406142
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer.
Sheng J; Xue X; Jiang K
Curr Mol Med; 2019; 19(2):147-155. PubMed ID: 30854965
[TBL] [Abstract][Full Text] [Related]
18. A novel inhibitory anti-invasive MAb isolated using phenotypic screening highlights AnxA6 as a functionally relevant target protein in pancreatic cancer.
O'Sullivan D; Dowling P; Joyce H; McAuley E; McCann A; Henry M; McGovern B; Barham P; Kelleher FC; Murphy J; Kennedy S; Swan N; Moriarty M; Clynes M; Larkin A
Br J Cancer; 2017 Oct; 117(9):1326-1335. PubMed ID: 28881357
[TBL] [Abstract][Full Text] [Related]
19. FOXO3a expression is associated with lymph node metastasis and poor disease-free survival in triple-negative breast cancer.
Rehman A; Kim Y; Kim H; Sim J; Ahn H; Chung MS; Shin SJ; Jang K
J Clin Pathol; 2018 Sep; 71(9):806-813. PubMed ID: 29588373
[TBL] [Abstract][Full Text] [Related]
20. Annexin A6 is a scaffold for PKCα to promote EGFR inactivation.
Koese M; Rentero C; Kota BP; Hoque M; Cairns R; Wood P; Vilà de Muga S; Reverter M; Alvarez-Guaita A; Monastyrskaya K; Hughes WE; Swarbrick A; Tebar F; Daly RJ; Enrich C; Grewal T
Oncogene; 2013 Jun; 32(23):2858-72. PubMed ID: 22797061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]